A comprehensive review on the development of chiral Cu, Ni, and Zn complexes as pharmaceutical agents over the past decades: Synthesis, molecular structure and biological activity
Medicinal Research Reviews · 2025
DOI: 10.1002/med.22083 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, 2025. Verfasst von Zahra Kazemi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Isfahan, Isfahan, Iran. Hauptthemen laut MEDLINE: Coordination Complexes, Nickel, Zinc, Copper. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 294 Literaturangaben.
Abstract (Originalsprache)
Chirality is a fundamental and widespread geometric structural property in living organisms that most biomacromolecules including nucleic acids, proteins and enzymes, possess. Consequently, the development of chiral drugs capable of binding specific targets have gradually gained wide attention in recent decades due to their selective effects on a broad spectrum of biological events ranging from cell metabolism to cell fate. In this context, the synthesis of chiral compounds as promising therapeutic candidates has assumed a major role in drug discovery. Among them, chiral metal complexes have attracted considerable interest due to their unique and intriguing structural features that could enable overcoming side effects and drug‐resistance phenomena of metal − based drugs currently in the market such as cisplatin. In the current scenario, an in‐depth overview of non‐platinum chiral complexes needs to be presented and carried forward. Therefore, in this perspective article, an update of the scientific development of bioactive chiral copper, zinc and nickel complexes have been reported since they have not been thoroughly reviewed so far. Specifically, we focused the article mainly on metal complexes containing chiral ligands (type 2 chirality) as in literature they are more numerous than those with chirality at the metal center (type 1 chirality). Herein, not only their biological activity but also their mechanism of action is summarized. Furthermore, in the final section of the article we have highlighted copper‐based complexes as those with a superior biological activity profile and greater prospects for development as a drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Isfahan, Isfahan, Iran.
- Department of Inorganic Chemistry, Faculty of Chemistry, Alzahra University, Tehran, Iran.
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
ORCID-Profile: Zahra Kazemi, Nakisa Moini, Hadi Amiri Rudbari, Nicola Micale
Zitieren
APA
Kazemi, Z., Moini, N., Rudbari, H. A., & Micale, N. (2025). A comprehensive review on the development of chiral Cu, Ni, and Zn complexes as pharmaceutical agents over the past decades: Synthesis, molecular structure and biological activity. Medicinal Research Reviews. https://doi.org/10.1002/med.22083
Vancouver
Kazemi Z, Moini N, Rudbari HA, Micale N. A comprehensive review on the development of chiral Cu, Ni, and Zn complexes as pharmaceutical agents over the past decades: Synthesis, molecular structure and biological activity. Medicinal Research Reviews. 2025. doi:10.1002/med.22083
BibTeX
@article{Kazemi2025,
author = {Kazemi, Zahra and Moini, Nakisa and Rudbari, Hadi Amiri and Micale, Nicola},
title = {A comprehensive review on the development of chiral Cu, Ni, and Zn complexes as pharmaceutical agents over the past decades: Synthesis, molecular structure and biological activity},
journal = {Medicinal Research Reviews},
year = {2025},
doi = {10.1002/med.22083}
}
EUVIMED